| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 302 | 2.083 | 12.324 | 17.605 | 15.334 | 10.538 | 19.770 | 35.278 | 21.854 | 23.966 |
| Total Income - EUR | 302 | 2.083 | 12.324 | 17.618 | 15.334 | 10.538 | 21.727 | 35.278 | 21.854 | 23.966 |
| Total Expenses - EUR | 2.798 | 3.034 | 12.279 | 15.922 | 15.973 | 11.108 | 19.416 | 31.055 | 23.691 | 21.430 |
| Gross Profit/Loss - EUR | -2.496 | -951 | 45 | 1.696 | -639 | -570 | 2.311 | 4.224 | -1.837 | 2.536 |
| Net Profit/Loss - EUR | -2.505 | -1.014 | -325 | 1.168 | -1.099 | -866 | 1.718 | 3.326 | -1.837 | 1.476 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Rovex Medica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5.054 | 4.534 |
| Current Assets | 4.063 | 3.154 | 5.557 | 10.887 | 9.942 | 8.662 | 11.563 | 13.730 | 16.989 | 19.592 |
| Inventories | 281 | 984 | 1.678 | 1.649 | 4.121 | 4.298 | 5.576 | 4.111 | 4.826 | 5.175 |
| Receivables | 275 | 1.451 | 1.897 | 2.848 | 4.105 | 3.638 | 5.322 | 6.769 | 8.162 | 9.746 |
| Cash | 3.507 | 719 | 1.982 | 6.390 | 1.717 | 726 | 665 | 2.849 | 4.001 | 4.671 |
| Shareholders Funds | 3.865 | 2.812 | 2.439 | 3.562 | 2.395 | 1.484 | 3.169 | 6.504 | 4.647 | 6.098 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 198 | 342 | 3.118 | 7.324 | 7.548 | 7.178 | 8.394 | 7.226 | 17.396 | 18.029 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4619 - 4619" | |||||||||
| CAEN Financial Year |
4619
|
|||||||||
Comments - Rovex Medica Srl